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Methods: Rat chondrosarcoma (RCS) cells were transiently
transfected with cDNA constructs encoding Cd-rap in the pres-
ence of TNF-alpha. The effect of TNF-alpha on endogenous
binding of C/EBPbets or Sox9 to the Cd-rap promoter was ex-
amined by chromatin immunoprecipitation (ChiP) assays.
Results: We identified a new C/EBP binding site in the Cd-
rap promoter located at position -1059 to -1046. This site is
responsive to TNF-alpha resulting in down-regulation of Cd-rap
expression. These effects were reversed by mutational inactiva-
tion of this C/EBP binding site. The activation potential of Sox9
and CBP/p300 on the Cd-rap promoter was enhanced after
mutation of the new C/EBP binding site.
Conclusions: TNF-alpha may regulate the balance of positive
and negative transcription factors to control the expression of
specific cartilage matrix genes such as Cd-rap.
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Purpose: Articular chondrocytes use glucose both for energy
production and for the synthesis of matrix components. In car-
tilage the quantities of available glucose and oxygen diminish
with the proximity to the calcified cartilage layer, thus chondro-
cytes are expected to adjust to variations in glucose and oxygen,
and respond appropriately by altering their metabolic rate. The
main source of ATP in cartilage is anaerobic glycolysis, and
a decreased supply of oxygen leads to preferential utilization
and enhancement of this pathway, with glucose transport rate as
the limiting step. Various facilitative glucose transporters (GLUT),
including GLUT-1, 3 and 9, have been identified in articular chon-
drocytes, although the mechanisms that regulate their expression
and function in physiological and pathological conditions are not
fully understood. The aim of this study was to determine if C-
28/I2 human chondrocyte-like cells can be used as a suitable in
vitro model to study the expression and functionality of glucose
transporters.
Methods: C-28/I2 human chondrocyte like cells were grown in
D-MEM: F12 with 10% foetal bovine serum. When the cultures
reached near confluency, the medium was replaced with fresh
D-MEM: F12 supplemented with 1% serum and the cells were
either placed in 20% O2 incubator or in a 5% O2 incubator
overnight before chemical stimulation with the hypoxia mimetic
CoCl2 (added at a final concentration of 75μM) for another 48h.
Net facilitated glucose transport was calculated by measuring
the uptake of non-metabolizable Deoxy-D-Glucose, 2-[1,2-3H(N)]
for 2 hours at 37°C into chondrocytes. Expression of the GLUT-1
glucose transporter protein was evaluated in total protein extracts
by western blot analysis.
Results: Net glucose transport was significantly higher in chon-
drocytes maintained in hypoxia (135.33% increase compared to
normoxia controls, ±3.5, n=4); exposure of C-28/I2 chondrocytes
to CoCl2 both in normoxia (153.24%, ±16.7, n=4) and hypoxia
conditions also resulted in a significant increase in net glucose
uptake (159.68% increase compared to controls, ±14.1, n=4).
Statistical analysis was carried out using the one-way ANOVA
test and the means were found to be significantly different.
(p=0.0107, Significance level: p <0.05). The GLUT-1 protein was
detected as a 55 kDa protein in whole cell extracts of C-28/I2
chondrocyte like cells.
Conclusions: The western blot results confirmed that C-28/I2
human chondrocyte-like cells express the GLUT-1 protein which
may be the functional glucose transporter involved in the in-
creased glucose uptake in cells exposed to hypoxia and CoCl2
treatment. These results indicate that the response of the C-28/I2
cells to hypoxia is similar to that of normal articular chondrocytes,
suggesting that this cell line is a suitable in vitro model for stud-
ies of glucose transporter expression and function in a variety of
experimental conditions including normoxia, hypoxia and hypoxia
mimicking.
P180
PROSTAGLANDIN E2 INDUCES MITOCHONDRIAL
DYSFUNCTION IN OSTEOARTHRITIC CHONDROCYTES
AND EXERTS CATABOLIC EFFECTS VIA THE EP4
RECEPTOR
M. Attur, M. Dave, J. Patel, H. Al-Mussawir, M.H. Pillinger,
S.B. Abramson
NYU Hospital for Joint Diseases, New York, NY
Purpose: OA cartilage explants spontaneously produce multi-
ple cyclooxygenase and lipoxygenase products including PGE2,
PGD2, and LTB4. PGE2, the predominant eicosanoid, signals
